{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:36:24Z","timestamp":1776954984009,"version":"3.51.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Brugada syndrome (BrS) is an inherited cardiac arrhythmia characterized by ST-elevation, negative T-wave, and a high risk of sudden cardiac death (SCD) due to ventricular tachycardia. It is associated with mutations in over 20 genes but only <jats:italic>SCN5A<\/jats:italic> is recommended for routine genetic screening. This study was performed to estimate diagnostic yield and pathogenicity assessment of rare genetic variants in the genes encoding Nav1.5 channel in Russian patients with Brugada syndrome (BrS). Targeted genes panel sequencing of the five genes were screened using IonTorrent PGM with following Sanger confirmation. Detailed clinical evaluation of 75 unrelated BrS probands with a deep phenotyping of SCN5A (+) probands was performed. Twelve rare genetic variants (six missense, six truncating) were initially identified and classified as disease-causing. Reassessment of the clinical significance in the light of the current guidelines revealed: 2 Pathogenic (P) variants; 8 Likely Pathogenic (LP); two missense variants (p.G274S and p. S1778H) were re-classified later as a variant of uncertain significance (VUS). Unique VUS (p.Arg100Ser) was detected in the <jats:italic>SCN4B<\/jats:italic> gene. Lone Brugada-pattern was observed in 46% probands; 54% patients had concomitant arrhythmias. PR interval, the only electrocardiography parameter correlating with SCN5A-mutation, was longer (207 \u00b1 24\u00a0ms) than normal in SCN5A (+) probands. SCD cases were registered in 31 families. Depression was the only recurring extra-cardiac complaint in SCN5A (+) probands; it was self-reported in five SCN5A (+) probands, and co-segregated with Brugada pattern in 2 families. After variants reassessment, the ratio of SCN5A (+) probands with Brugada syndrome accounts for 13% in Russian cohort.<\/jats:p>","DOI":"10.3389\/fphar.2022.984299","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T07:19:38Z","timestamp":1661325578000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic yield and variant reassessment in the genes encoding Nav1.5 channel in Russian patients with Brugada syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Elena","family":"Zaklyazminskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Shestak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Podolyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Komoliatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Novitskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amiran","family":"Revishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1113\/JP274536","article-title":"Differential calcium sensitivity in NaV 1.5 mixed syndrome mutants","volume":"595","author":"Abdelsayed","year":"2017","journal-title":"J. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/01.cir.102.8.921","article-title":"Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome","volume":"102","author":"Abriel","year":"2000","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2054270416640153","DOI":"10.1177\/2054270416640153","article-title":"Intoxication with alcohol: an underestimated trigger of Brugada syndrome?","volume":"7","author":"Achaiah","year":"2016","journal-title":"JRSM open"},{"key":"B4","volume-title":"Brugada Phenocopy: The art of recognizing the Brugada ECG pattern","author":"Baranchuk","year":"2018"},{"key":"B5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jelectrocard.2012.06.004","article-title":"Current electrocardiographic criteria for diagnosis of brugada pattern: a consensus report","volume":"45","author":"Bay\u00e9s de Luna","year":"2012","journal-title":"J. Electrocardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pcad.2008.05.002","article-title":"Brugada syndrome","volume":"51","author":"Benito","year":"2008","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/01.cir.97.5.457","article-title":"Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease","volume":"97","author":"Brugada","year":"1998","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-pharmtox-011112-140232","article-title":"Sodium channels, inherited epilepsy, and antiepileptic drugs","volume":"54","author":"Catterall","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"478397","DOI":"10.1155\/2014\/478397","article-title":"Treatment of anxiety and depression in a patient with brugada syndrome","volume":"2014","author":"Chen","year":"2014","journal-title":"Case Rep. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e003631","DOI":"10.1161\/CIRCEP.115.003631","article-title":"Relationship between arrhythmogenic right ventricular cardiomyopathy and brugada syndrome: New insights from molecular biology and clinical implications","volume":"9","author":"Corrado","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"A15","DOI":"10.1136\/heartjnl-2018-ICS.20","article-title":"20 the role of SCN5A mutations in hypertrophic cardiomyopathy","volume":"104","author":"Cronin","year":"2018","journal-title":"Heart"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajem.2016.10.063","article-title":"Not all ST-segment elevations are myocardial infarction: Hyperkalemia and Brugada phenocopy","volume":"35","author":"Dendramis","year":"2017","journal-title":"Am. J. Emerg. Med."},{"key":"B14","first-page":"55","article-title":"Frequency of detection the of Brugada syndrome signs in the course of ECG registration","volume":"47","author":"Dupliakov","year":"2007","journal-title":"Kardiologiia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fcell.2019.00261","article-title":"Studying brugada syndrome with an SCN1B variants in human-induced pluripotent stem cell-derived cardiomyocytes","volume":"7","author":"El-Battrawy","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/cardiogenetics11030016","article-title":"Mutations in MYBPC3 and MYH7 in association with brugada type 1 ECG pattern: Overlap between brugada syndrome and hypertrophic cardiomyopathy?","volume":"11","author":"Farn\u00e8","year":"2021","journal-title":"Cardiogenetics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajhg.2020.05.015","article-title":"High-throughput reclassification of SCN5A variants","volume":"107","author":"Glazer","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/europace\/euv278","article-title":"Expert cardiologists cannot distinguish between brugada phenocopy and brugada syndrome electrocardiogram patterns. Europace : European pacing, arrhythmias, and cardiac electrophysiology","volume":"18","author":"Gottschalk","year":"2016","journal-title":"Europace"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0124921","DOI":"10.1371\/journal.pone.0124921","article-title":"Arrhythmogenic biophysical phenotype for SCN5A mutation S1787N depends upon splice variant background and intracellular acidosis","volume":"10","author":"Hu","year":"2015","journal-title":"PloS one"},{"key":"B20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000076693","article-title":"Brugada syndrome--an under-recognized electrical disease in patients with sudden cardiac death","volume":"101","author":"Juang","year":"2004","journal-title":"Cardiology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/gim.2018.33","article-title":"Phenotypic expansion illuminates multilocus pathogenic variation","volume":"20","author":"Karaca","year":"2018","journal-title":"Genet. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.amjcard.2009.08.676","article-title":"Mutation-specific risk in two genetic forms of type 3 long QT syndrome","volume":"105","author":"Liu","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1572-0241.2006.00507.x","article-title":"Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy","volume":"101","author":"Locke","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur. Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/0002-8703(89)90011-2","article-title":"Ventricular fibrillation without apparent heart disease: description of six cases","volume":"118","author":"Martini","year":"1989","journal-title":"Am. Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1161\/01.cir.96.8.2595","article-title":"Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men","volume":"96","author":"Nademanee","year":"1997","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)","volume":"6","author":"Postema","year":"2009","journal-title":"Heart R"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/j.hrthm.2013.07.021","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"B29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCGENETICS.109.853374","article-title":"SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome","volume":"2","author":"Probst","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12256","DOI":"10.14814\/phy2.12256","article-title":"Complex genetic background in a large family with Brugada syndrome","volume":"3","author":"Saber","year":"2015","journal-title":"Physiol. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.106.628537","article-title":"Outcome after implantation of a cardioverter-defibrillator in patients with brugada syndrome: a multicenter study","volume":"114","author":"Sacher","year":"2006","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1161\/CIRCEP.114.002647","article-title":"Prognostic value of programmed electrical stimulation in brugada syndrome: 20 years experience","volume":"8","author":"Sieira","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/s0735-1097(02)01962-9","article-title":"Genotype-phenotype relationship in brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients","volume":"40","author":"Smits","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/01.cir.102.10.1178","article-title":"Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2","volume":"102","author":"Splawski","year":"2000","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.6515\/ACS.201805_34(3).20180302B","article-title":"Worldwide prevalence of brugada syndrome: A systematic review and meta-analysis","volume":"34","author":"Vutthikraivit","year":"2018","journal-title":"Acta Cardiol. Sin."},{"key":"B37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41436-020-00946-5","article-title":"Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls","volume":"23","author":"Walsh","year":"2021","journal-title":"Genet. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/19336950.2020.1805999","article-title":"Calmodulin binds to the N-terminal domain of the cardiac sodium channel Nav1.5","volume":"14","author":"Wang","year":"2020","journal-title":"Channels (Austin, Tex.)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e002911","DOI":"10.1161\/CIRCGEN.120.002911","article-title":"SCN5A mutation type and a genetic risk score associate variably with brugada syndrome phenotype in SCN5A families","volume":"13","author":"Wijeyeratne","year":"2020","journal-title":"Circ. Genom. Precis. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacep.2018.03.006","article-title":"Clinical spectrum of SCN5A mutations: Long QT syndrome, brugada syndrome, and cardiomyopathy","volume":"4","author":"Wilde","year":"2018","journal-title":"JACC. Clin. Electrophysiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.984299\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T07:19:42Z","timestamp":1661325582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.984299\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":39,"alternative-id":["10.3389\/fphar.2022.984299"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.984299","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"article-number":"984299"}}